Aurinia Pharmaceuticals (AUPH) Metrics: History & Chart

Aurinia Pharmaceuticals Inc.(AUPH)

Biotechnology · Edmonton, AB

$15.71-0.01 (-0.07%)

Delayed quote: Oct 6, 2026, 2:55 PM EDT

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical company, specializing in the development and commercialization of innovative therapies. Its core mission is to address a variety of diseases for which current medical solutions are inadequate, serving patient populations across the United States and internationally. The company's flagship product is LUPKYNIS, an approved treatment designed for adult individuals suffering from active lupus nephritis. Furthermore, Aurinia maintains a strategic collaboration and licensing agreement with Otsuka Pharmaceutical Co., Ltd. The firm's main corporate office is located in Victoria, Canada.

Edmonton, AB

128 employees

www.auriniapharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Kevin C. Tang

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-4.84%
30D Total Return	-2.24%
YTD Total Return	-1.44%
1Y Total Return	+38.50%
3Y Total Return	+116.21%
5Y Total Return	-26.14%
10Y Total Return	+288.25%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-1.44%
2025	+77.62%
2024	-0.11%
2023	+108.10%
2022	-81.11%
2021	+65.37%
2020

CAGR TTM	+38.29%
CAGR 3Y	+29.30%
CAGR 5Y	-5.88%
CAGR 10Y	+14.53%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	6.86
PE Ratio Avg TTM	15.39
PE Ratio Avg 3Y	19.38
Current VS TTM Avg	-55.41%
Current VS 3Y Avg	-64.59%
Current VS 5Y Avg	-64.59%

All Metrics

AUPH Valuation Metrics

AUPH Stock Price Metrics

AUPH Dividend Metrics

AUPH Growth Rate Metrics

AUPH Discounted Cash Flow Metrics

AUPH Returns By Period

AUPH Yearly Returns

AUPH Average Annual Returns By Period (CAGR)

AUPH Revenue Metrics

AUPH PE Ratio Metrics

AUPH PS Ratio Metrics

AUPH PB Ratio Metrics

AUPH Price to Free Cash Flow Ratio Metrics

AUPH Debt to Equity Ratio Metrics

AUPH PEG Ratio Metrics

AUPH FCF Yield

AUPH Earnings Yield

AUPH EBITDA Yield

AUPH OCF Yield

AUPH EV/EBIT Ratio Metrics

AUPH EV/EBITDA Ratio Metrics

AUPH EV/Assets Ratio Metrics

AUPH EV/Sales Ratio Metrics

AUPH Current Ratio Metrics

AUPH Quick Ratio Metrics

AUPH ROIC Metrics

AUPH Return on Assets Metrics

AUPH Return on Equity Metrics

AUPH Net Profit Margin Metrics

AUPH Gross Profit Margin Metrics

AUPH Tax Rate Metrics

PS Ratio	6.74
PS Ratio Avg TTM	7.36
PS Ratio Avg 3Y	6.09
Current VS TTM Avg	-8.36%
Current VS 3Y Avg	+10.64%
Current VS 5Y Avg	-5.91%

PB Ratio	3.41
PB Ratio Avg TTM	4.41
PB Ratio Avg 3Y	3.27
Current VS TTM Avg	-22.72%
Current VS 3Y Avg	+4.14%
Current VS 5Y Avg	+4.67%

PFCF Ratio	12.09
PFCF Ratio Avg TTM	15.26
PFCF Ratio Avg 3Y	19.07
Current VS TTM Avg	-20.80%
Current VS 3Y Avg	-36.60%
Current VS 5Y Avg	-36.60%

Debt/Equity Ratio	0.10
Debt/Equity Ratio Avg TTM	0.16
Debt/Equity Ratio Avg 3Y	0.24
Current VS TTM Avg	-39.02%
Current VS 3Y Avg	-58.24%
Current VS 5Y Avg	-28.21%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	8.27%
FCF Yield Avg TTM	6.70%
FCF Yield Avg 3Y	5.44%
Current VS TTM Avg	+23.49%
Current VS 3Y Avg	+52.09%
Current VS 5Y Avg	+52.09%

Earnings Yield	14.57%
Earnings Yield Avg TTM	9.78%
Earnings Yield Avg 3Y	7.02%
Current VS TTM Avg	+49.02%
Current VS 3Y Avg	+107.47%
Current VS 5Y Avg	+107.47%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	13.13
Ev/Ebit Ratio Avg TTM	22.52
Ev/Ebit Ratio Avg 3Y	26.44
Current VS TTM Avg	-41.70%
Current VS 3Y Avg	-50.35%
Current VS 5Y Avg	-50.35%

Ev/Ebitda Ratio	11.64
Ev/Ebitda Ratio Avg TTM	18.29
Ev/Ebitda Ratio Avg 3Y	19.90
Current VS TTM Avg	-36.37%
Current VS 3Y Avg	-41.50%
Current VS 5Y Avg	-41.50%

Ev/Assets Ratio	2.50
Ev/Assets Ratio Avg TTM	3.23
Ev/Assets Ratio Avg 3Y	2.59
Current VS TTM Avg	-22.59%
Current VS 3Y Avg	-3.39%
Current VS 5Y Avg	-1.01%

Ev/Sales Ratio	6.36
Ev/Sales Ratio Avg TTM	7.33
Ev/Sales Ratio Avg 3Y	6.20
Current VS TTM Avg	-13.20%
Current VS 3Y Avg	+2.59%
Current VS 5Y Avg	-9.36%

Current Ratio	5.42
Current Ratio Avg TTM	5.44
Current Ratio Avg 3Y	5.54
Current VS TTM Avg	-0.38%
Current VS 3Y Avg	-2.18%
Current VS 5Y Avg	-30.38%

Quick Ratio	4.97
Quick Ratio Avg TTM	4.91
Quick Ratio Avg 3Y	5.01
Current VS TTM Avg	+1.20%
Current VS 3Y Avg	-0.82%
Current VS 5Y Avg	-31.23%

ROIC	21.77%
ROIC Avg 3Y	(0.04%)
ROIC Avg 5Y	(13.06%)
Current VS 3Y Avg	+58442.52%
Current VS 5Y Avg	+266.68%
Current VS 10Y Avg	+183.61%

ROA	39.65%
ROA Avg TTM	9.56%
ROA Avg 3Y	1.32%
Current VS TTM Avg	+314.96%
Current VS 3Y Avg	+2899.62%
Current VS 5Y Avg	+1887.61%

ROE	51.09%
ROE Avg TTM	38.48%
ROE Avg 3Y	8.41%
Current VS TTM Avg	+32.78%
Current VS 3Y Avg	+507.17%
Current VS 5Y Avg	+701.79%

Net Profit Margin	100.84%
Net Profit Margin Avg TTM	87.24%
Net Profit Margin Avg 3Y	7.64%
Current VS TTM Avg	+15.59%
Current VS 3Y Avg	+1219.43%
Current VS 5Y Avg	+439.57%

Gross Profit Margin	90.36%
Gross Pft Margin Avg TTM	90.21%
Gross Pft Margin Avg 3Y	89.23%
Current VS TTM Avg	+0.17%
Current VS 3Y Avg	+1.27%
Current VS 5Y Avg	-1.90%

Tax Rate	23.31%
Tax Rate Avg 3Y	(44.98%)
Tax Rate Avg 5Y	(44.98%)
Current VS 3Y Avg	+151.83%
Current VS 5Y Avg	+151.83%
Current VS 10Y Avg	+151.83%